The therapeutic effect of Nigel/a sativa seed oil in treatment of chronic urticaria
DOI:
https://doi.org/10.25130/tjphs.2005.1.1.1.6Abstract
Urticaria is a common disease which affects an approximately 15-25% of the population at some point during their life time. Chronic urticaria indicates the presence of hives for a protracted period (>6weeks). Antihistamines, steroids and immune suppressants are needed for the treatment of chronic miicaric. This study was designed to investigate the therapeutic effects of Nigella sative oil in the treatment of chronic urticaria. The results showed that 400 mg twice daily of Nigella sativa oil (in gelatin capsule) was significantly increase cure rate. It also significantly decreases log1 o IgE and improves tolerability of patients to exacerbating factors. The effects of Nigella sativa oil in urticaria could be attributed to inhibition of histamine release, blocking of histamine effects and inhibition of ecosanoides formation from arachidonic acid.
References
.. Kaplan, AP. Urticaria and angioedema. In Immunological diseases.Edited by Mickael MF Samters. Little Brown and Co. New York, 1995;1329-1333 .
- Odom, RB. , James, WD, and Berger, TG. Andrews diseases of skin. 9th ed. Voll, Philadelphia W.B. Saunders Co. 2000; 160-170.
- Black, AK and Champion, RH. Urticaria. In : Rook, Wilkinson and Ebling text book of dermatology Edited by Champion, RH. ; Burton . JL. And Breathnach, SM . 61h ed . Blackwell Science Ltd 1998; 2113- 2 l 26.
- Bressler, RB. Pathophysiolog of urticaria. Immunol. Allergy Clinic North Am. 1995;15: 659-677 .
- Kaplan, AP. , Horakova, Z and Katz, SI. Assessment of tissue fluid histamine levels in patients with urticaria . J.Allergy Cin. Immunol. 1978;61 : 350-354 .
- Kobza Black, A. , Greaves, MW. , Champion, RH. et al. The urticarias. Br. J. Dermatol. 1991; 114:100-108 .
- Kobza Black, A. and Grattan, CE. The medication involved in acute and chronic urticaria and their therapeutic implications. In: Recent advance in dermatology, edited by Champion, RI-I. and Pye, RJ. Churchill Livingston 1992: 119-132 .
Niimi, N.,Francis, DM. Kermani, F. et al . Dermal mast cell activation by autoantibodies against the high affinity lgE receptor in chronic urticaria .J. Invest. Dermatol. 1996, 106: 1001-1006 .
- Haslett, C. , chilvers, ER. , Boon, NA . and Colledge, NR. Davidsons principles and practice of medicine. 19th ed. Churchill, Livingstone 2002:1061-1063.
- Mohmmod, KS. The role of Nigella sative extract in treatment of astlm1a. M.Sc thesis,Tikrit college of medicine 2000.
- Hamid, MA . Therapeutic effect of Nigella sativa extract in allergic rhinitis, M.Sc. thesis, Tikrit college of medicine 2002
- Chakravarty, N. Inhibition of histamine release from mast cells by Nigellone.Annals Allergy 1993 :23 7- 242.
- El-Dakhakhny, M. Studies of Egyptian Nigella sativa L. , some pharmacological properties of the seeds active principle in comparison to dihydro compoimds and its po1ymer Arzneimittel-Forsch 1965; (10) : 1227-1229 .
- Boskabady, MH. and Shahbi, M. Test on effects of black seed on astluna, bronchodilatory and anticholinergic effects of Nigella sativa on isolated guinea pig trachea chain . Irn. J. Med. Sc. 1997; 22 (3 and 4): 133-139 .
- ahfouz, M. and El -Dahhakhng ,M. Chemical and pharmacological properties of new antihistamine drug, nigellone . Egypt Phann. Bull. 1960, 42: 411-424.
-Mahfouz, M. , Abdel-Maguid, R. and El-Dakhakhny, M. The effect of Nigellone therapy on the histaminopexic power of the blood sera of asthmatic patients. Arzneimittel- Forsch 1965; 15: 1230 -1231 .
-Houghton, PJ. and Zarka, R. Fixedoil of Nige!la sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane peroxidation . Plant Medica 1995; 61 : 33-36.
-Yoshimoto, T. , Furukawa, M. , Yomamoto, S. et al. Flavonoids : potent inhibitors of arachidonate 5-1poxygenase.
Biochem . Biophys. Res. Comm. 198 3; 116(2): 612-618.
-Havsteen, B. Flavonoids, a class of natural products of high pharmacological potency. Pharmacol. 1983; 32(7): 1141-1148.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal, and all journal content is available for readers free of charge immediately upon publication.
